Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated May 17, 2021. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2021. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 19.6B USD
- Positions
- 873
- Share of the ten largest
- 15.1%
The ten largest positions Q1 2021
- Uber 2.4%▲ +117.8%
- Western Digital 1.8%▲ +1,932.1%
- Baidu (ADR) 1.8%▲ +602.0%
- Visa Inc. 1.6%▲ +12.6%
- Alphabet Inc. (Class A) 1.4%▼ −63.8%
- Applied Materials 1.3%new
- Amazon 1.3%▲ +71.1%
- Meta Platforms 1.2%▼ −27.6%
- Dxc Technology Co 1.2%▲ +147.5%
- Twitter Inc 1.2%▲ +6.7%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q1 2021
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| GOOGL Alphabet Inc. (Class A) | 1.4% | 128,782 | 265.6M USD | −63.8% reduced | Q2 2020 4 quarters |
| META Meta Platforms | 1.2% | 820,283 | 241.6M USD | −27.6% reduced | Q2 2020 4 quarters |
| MU Micron Technology | 0.9% | 2,100,875 | 185.3M USD | −19.2% reduced | Q2 2019 8 quarters |
| AZN AstraZeneca | 0.9% | 3,552,847 | 176.6M USD | −16.2% reduced | Q1 2020 5 quarters |
| MSFT Microsoft | 0.7% | 596,055 | 140.5M USD | −42.2% reduced | Q1 2020 5 quarters |
| DELL Dell Technologies | 0.7% | 1,485,400 | 130.9M USD | −45.6% reduced | Q2 2019 8 quarters |
| MRK Merck & Co. | 0.6% | 1,580,000 | 121.8M USD | −2.1% reduced | Q2 2020 4 quarters |
| RTX RTX Corporation | 0.6% | 1,572,759 | 121.5M USD | −16.7% reduced | Q2 2020 4 quarters |
| L Brands Inc | 0.6% | 1,838,876 | 113.8M USD | −46.4% reduced | Q2 2019 8 quarters |
| FIVE9 Inc | 0.5% | 642,300 | 100.4M USD | −11.8% reduced | Q3 2020 3 quarters |
| COF Capital One | 0.5% | 706,289 | 89.9M USD | −54.4% reduced | Q3 2015 23 quarters |
| JD JD.com (ADR) | 0.4% | 1,024,325 | 86.4M USD | −50.6% reduced | Q4 2018 10 quarters |
| MCHP Microchip Technology | 0.4% | 556,318 | 86.4M USD | −47.0% reduced | Q2 2019 8 quarters |
| TMUS T-Mobile US | 0.4% | 633,800 | 79.4M USD | −39.6% reduced | Q2 2020 4 quarters |
| Open Lending Corp | 0.4% | 2,209,202 | 78.3M USD | −12.9% reduced | Q3 2020 3 quarters |
| DRI Darden Restaurants | 0.4% | 545,483 | 77.5M USD | −35.6% reduced | Q4 2020 2 quarters |
| DHR Danaher Corporation | 0.4% | 331,177 | 74.5M USD | −24.9% reduced | Q1 2020 5 quarters |
| Repligen Corp | 0.3% | 341,567 | 66.4M USD | −10.4% reduced | Q3 2018 11 quarters |
| Crown HLDGS Inc | 0.3% | 664,867 | 64.5M USD | −5.9% reduced | Q3 2020 3 quarters |
| LVS Las Vegas Sands | 0.3% | 1,023,183 | 62.2M USD | −66.1% reduced | Q3 2018 11 quarters |
| Alnylam Pharmaceuticals Inc | 0.3% | 439,937 | 62.1M USD | −8.7% reduced | Q4 2020 2 quarters |
| TPR Tapestry, Inc. | 0.3% | 1,423,077 | 58.6M USD | −3.2% reduced | Q4 2020 2 quarters |
| ADI Analog Devices | 0.3% | 375,247 | 58.2M USD | −22.0% reduced | Q2 2020 4 quarters |
| Pinterest Inc | 0.3% | 731,511 | 54.2M USD | −51.0% reduced | Q2 2020 4 quarters |
| D Dominion Energy | 0.3% | 697,894 | 53.0M USD | −37.2% reduced | Q4 2020 2 quarters |
| Zendesk Inc | 0.3% | 379,639 | 50.3M USD | −17.5% reduced | Q3 2020 3 quarters |
| 21VIANET Group Inc | 0.3% | 1,555,300 | 50.2M USD | −11.7% reduced | Q3 2020 3 quarters |
| Seaworld Entmt Inc | 0.3% | 1,011,345 | 50.2M USD | −41.0% reduced | Q3 2020 3 quarters |
| GM General Motors | 0.2% | 800,140 | 46.0M USD | −10.7% reduced | Q2 2020 4 quarters |
| PG Procter & Gamble | 0.2% | 324,310 | 43.9M USD | −35.2% reduced | Q2 2019 8 quarters |
| WDAY Workday, Inc. | 0.2% | 173,791 | 43.2M USD | −48.7% reduced | Q3 2020 3 quarters |
| HLT Hilton Worldwide | 0.2% | 349,434 | 42.3M USD | −49.3% reduced | Q4 2020 2 quarters |
| ACGL Arch Capital Group | 0.2% | 1,081,485 | 41.5M USD | −72.6% reduced | Q2 2019 8 quarters |
| SRE Sempra | 0.2% | 311,600 | 41.3M USD | −41.0% reduced | Q4 2020 2 quarters |
| Rackspace Technology Inc | 0.2% | 1,693,800 | 40.3M USD | −17.7% reduced | Q3 2020 3 quarters |
| ROST Ross Stores | 0.2% | 323,961 | 38.8M USD | −33.4% reduced | Q2 2019 8 quarters |
| Caesars Entertainment Inc Ne | 0.2% | 440,687 | 38.5M USD | −16.3% reduced | Q4 2020 2 quarters |
| Exelixis Inc | 0.2% | 1,686,254 | 38.1M USD | −50.0% reduced | Q1 2020 5 quarters |
| American Eagle Outfitters In | 0.2% | 1,293,244 | 37.8M USD | −39.2% reduced | Q1 2020 5 quarters |
| Cimarex Energy Co | 0.2% | 631,040 | 37.5M USD | −2.4% reduced | Q1 2016 21 quarters |
| Bandwidth Inc | 0.2% | 281,200 | 35.6M USD | −13.1% reduced | Q4 2018 10 quarters |
| MPC Marathon Petroleum | 0.2% | 662,035 | 35.4M USD | −41.8% reduced | Q4 2020 2 quarters |
| Ringcentral Inc | 0.2% | 118,541 | 35.3M USD | −51.7% reduced | Q2 2020 4 quarters |
| Lamb Weston HLDGS Inc | 0.2% | 441,710 | 34.2M USD | −9.7% reduced | Q1 2020 5 quarters |
| MNST Monster Beverage | 0.2% | 373,687 | 34.0M USD | −59.0% reduced | Q3 2020 3 quarters |
| BIIB Biogen | 0.2% | 115,400 | 32.3M USD | −41.9% reduced | Q3 2020 3 quarters |
| Kansas City Southern | 0.1% | 110,731 | 29.2M USD | −65.7% reduced | Q3 2020 3 quarters |
| C Citigroup | 0.1% | 400,000 | 29.1M USD | −54.6% reduced | Q4 2020 2 quarters |
| RUN Sunrun | 0.1% | 478,935 | 29.0M USD | −16.3% reduced | Q4 2020 2 quarters |
| Tempur Sealy Intl Inc | 0.1% | 783,000 | 28.6M USD | −41.9% reduced | Q1 2019 9 quarters |
| ICE Intercontinental Exchange | 0.1% | 243,500 | 27.2M USD | −39.5% reduced | Q1 2020 5 quarters |
| Boston Beer Inc | 0.1% | 21,858 | 26.4M USD | −37.8% reduced | Q4 2019 6 quarters |
| Markel Corp | 0.1% | 22,762 | 25.9M USD | −3.2% reduced | Q3 2020 3 quarters |
| PM Philip Morris International | 0.1% | 288,848 | 25.6M USD | −15.4% reduced | Q2 2020 4 quarters |
| Alliance Data Systems Corp | 0.1% | 227,901 | 25.5M USD | −71.9% reduced | Q4 2018 10 quarters |
| DD DuPont | 0.1% | 325,164 | 25.1M USD | −21.3% reduced | Q2 2019 8 quarters |
| TJX TJX Companies | 0.1% | 378,419 | 25.0M USD | −24.2% reduced | Q3 2020 3 quarters |
| Royal Dutch Shell PLC | 0.1% | 678,100 | 25.0M USD | −22.4% reduced | Q3 2020 3 quarters |
| Equitable HLDGS Inc | 0.1% | 737,000 | 24.0M USD | −63.3% reduced | Q1 2020 5 quarters |
| Gap Inc | 0.1% | 792,114 | 23.6M USD | −52.0% reduced | Q3 2020 3 quarters |
| First Bancorp P R | 0.1% | 2,073,700 | 23.4M USD | −17.0% reduced | Q1 2015 25 quarters |
| Brightsphere Invt Group Inc | 0.1% | 1,120,546 | 22.8M USD | −20.8% reduced | Q3 2019 7 quarters |
| Bellus Health Inc New | 0.1% | 5,800,000 | 22.3M USD | −6.8% reduced | Q4 2020 2 quarters |
| COP ConocoPhillips | 0.1% | 418,962 | 22.2M USD | −74.8% reduced | Q3 2020 3 quarters |
| TRGP Targa Resources | 0.1% | 692,622 | 22.0M USD | −31.9% reduced | Q3 2019 7 quarters |
| AMD Advanced Micro Devices | 0.1% | 279,700 | 22.0M USD | −92.6% reduced | Q3 2020 3 quarters |
| ASML ASML Holding (ADR) | 0.1% | 35,400 | 21.9M USD | −3.1% reduced | Q3 2020 3 quarters |
| Sutro Biopharma Inc | 0.1% | 958,200 | 21.8M USD | −32.0% reduced | Q2 2020 4 quarters |
| AZO AutoZone | 0.1% | 15,308 | 21.5M USD | −85.5% reduced | Q1 2020 5 quarters |
| Syndax Pharmaceuticals Inc | 0.1% | 946,800 | 21.2M USD | −17.2% reduced | Q3 2020 3 quarters |
| Haemonetics Corp Mass | 0.1% | 189,700 | 21.1M USD | −32.4% reduced | Q1 2020 5 quarters |
| Revolve Group Inc | 0.1% | 464,266 | 20.9M USD | −71.8% reduced | Q1 2020 5 quarters |
| ODFL Old Dominion | 0.1% | 85,481 | 20.6M USD | −62.7% reduced | Q4 2019 6 quarters |
| Aercap Holdings NV | 0.1% | 345,015 | 20.3M USD | −28.9% reduced | Q3 2020 3 quarters |
| Signet Jewelers Limited | 0.1% | 346,200 | 20.1M USD | −24.7% reduced | Q3 2020 3 quarters |
| Ideaya Biosciences Inc | < 0.1% | 833,700 | 19.6M USD | −25.0% reduced | Q2 2019 8 quarters |
| Biomarin Pharmaceutical Inc | < 0.1% | 256,500 | 19.4M USD | −32.7% reduced | Q3 2020 3 quarters |
| DAL Delta Air Lines | < 0.1% | 392,692 | 19.0M USD | −30.6% reduced | Q2 2020 4 quarters |
| Replimune Group Inc | < 0.1% | 615,278 | 18.8M USD | −21.6% reduced | Q3 2020 3 quarters |
| Macrogenics Inc | < 0.1% | 577,700 | 18.4M USD | −60.4% reduced | Q1 2020 5 quarters |
| BNY BNY Mellon | < 0.1% | 385,700 | 18.2M USD | −36.9% reduced | Q3 2019 7 quarters |
| ORLY O'Reilly Automotive | < 0.1% | 35,778 | 18.1M USD | −31.8% reduced | Q4 2019 6 quarters |
| CCEP Coca-Cola Europacific Partners | < 0.1% | 339,369 | 17.7M USD | −29.5% reduced | Q4 2020 2 quarters |
| Proofpoint Inc | < 0.1% | 140,530 | 17.7M USD | −39.7% reduced | Q2 2020 4 quarters |
| INTU Intuit | < 0.1% | 44,700 | 17.1M USD | −35.3% reduced | Q3 2020 3 quarters |
| Post HLDGS Inc | < 0.1% | 160,114 | 16.9M USD | −58.3% reduced | Q4 2020 2 quarters |
| Avantor Inc | < 0.1% | 582,500 | 16.9M USD | −66.8% reduced | Q1 2020 5 quarters |
| Aramark | < 0.1% | 439,900 | 16.6M USD | −0.8% reduced | Q3 2020 3 quarters |
| BMY Bristol Myers Squibb | < 0.1% | 259,100 | 16.4M USD | −82.5% reduced | Q1 2020 5 quarters |
| Ovintiv Inc | < 0.1% | 679,633 | 16.2M USD | −29.2% reduced | Q3 2020 3 quarters |
| HCA HCA Healthcare | < 0.1% | 85,760 | 16.2M USD | −59.6% reduced | Q4 2017 14 quarters |
| Dicerna Pharmaceuticals Inc | < 0.1% | 606,439 | 15.5M USD | −74.4% reduced | Q4 2020 2 quarters |
| SHOP Shopify | < 0.1% | 13,992 | 15.5M USD | −51.5% reduced | Q2 2020 4 quarters |
| Selectquote Inc | < 0.1% | 521,461 | 15.4M USD | −9.0% reduced | Q2 2020 4 quarters |
| Ally Finl Inc | < 0.1% | 330,200 | 14.9M USD | −75.8% reduced | Q4 2019 6 quarters |
| Acadia Healthcare Company In | < 0.1% | 258,600 | 14.8M USD | −31.2% reduced | Q2 2020 4 quarters |
| Akero Therapeutics Inc | < 0.1% | 506,497 | 14.7M USD | −28.2% reduced | Q2 2019 8 quarters |
| Royal Dutch Shell PLC | < 0.1% | 362,891 | 14.2M USD | −69.3% reduced | Q2 2020 4 quarters |
| Ultragenyx Pharmaceutical In | < 0.1% | 119,600 | 13.6M USD | −0.1% reduced | Q4 2020 2 quarters |
| CMCSA Comcast | < 0.1% | 244,800 | 13.2M USD | −77.6% reduced | Q2 2020 4 quarters |
| XEL Xcel Energy | < 0.1% | 198,324 | 13.2M USD | −79.0% reduced | Q3 2020 3 quarters |
| Advance Auto Parts Inc | < 0.1% | 71,651 | 13.1M USD | −25.2% reduced | Q2 2018 12 quarters |
| Krystal Biotech Inc | < 0.1% | 169,000 | 13.0M USD | −66.2% reduced | Q2 2020 4 quarters |
| WTW Willis Towers Watson | < 0.1% | 55,853 | 12.8M USD | −48.2% reduced | Q3 2018 11 quarters |
| Arcutis Biotherapeutics Inc | < 0.1% | 439,300 | 12.7M USD | −49.8% reduced | Q3 2020 3 quarters |
| Scotts Miracle-Gro Co | < 0.1% | 51,221 | 12.5M USD | −44.3% reduced | Q3 2020 3 quarters |
| ELV Elevance Health | < 0.1% | 34,500 | 12.4M USD | −87.3% reduced | Q3 2020 3 quarters |
| Aeglea Biotherapeutics Inc | < 0.1% | 1,500,000 | 11.9M USD | −48.6% reduced | Q4 2020 2 quarters |
| Childrens Pl Inc New | < 0.1% | 168,996 | 11.8M USD | −42.5% reduced | Q1 2019 9 quarters |
| Bill Com HLDGS Inc | < 0.1% | 80,834 | 11.8M USD | −58.8% reduced | Q2 2020 4 quarters |
| Celanese Corp Del | < 0.1% | 76,906 | 11.5M USD | −59.4% reduced | Q4 2020 2 quarters |
| DXCM Dexcom | < 0.1% | 32,000 | 11.5M USD | −84.1% reduced | Q4 2015 22 quarters |
| Orthofix Med Inc | < 0.1% | 259,100 | 11.2M USD | −0.4% reduced | Q4 2020 2 quarters |
| Canadian Nat Res Ltd | < 0.1% | 363,000 | 11.2M USD | −84.5% reduced | Q2 2017 16 quarters |
| Inmode Ltd | < 0.1% | 152,500 | 11.0M USD | −36.7% reduced | Q4 2020 2 quarters |
| Evolent Health Inc | < 0.1% | 534,889 | 10.8M USD | −30.8% reduced | Q2 2020 4 quarters |
| CAH Cardinal Health | < 0.1% | 169,300 | 10.3M USD | −0.1% reduced | Q4 2020 2 quarters |
| Alphatec HLDGS Inc | < 0.1% | 637,300 | 10.1M USD | −57.8% reduced | Q4 2020 2 quarters |
| CRWD CrowdStrike | < 0.1% | 54,673 | 10.0M USD | −87.1% reduced | Q2 2019 8 quarters |
| CMS CMS Energy | < 0.1% | 161,108 | 9.9M USD | −43.8% reduced | Q4 2020 2 quarters |
| Heska Corp | < 0.1% | 56,657 | 9.5M USD | −30.9% reduced | Q4 2020 2 quarters |
| Copa Holdings SA | < 0.1% | 117,169 | 9.5M USD | −7.1% reduced | Q1 2019 9 quarters |
| Portland Gen Elec Co | < 0.1% | 198,336 | 9.4M USD | −7.7% reduced | Q3 2020 3 quarters |
| Under Armour Inc | < 0.1% | 411,010 | 9.1M USD | −71.2% reduced | Q4 2020 2 quarters |
| TMO Thermo Fisher Scientific | < 0.1% | 19,955 | 9.1M USD | −42.3% reduced | Q2 2020 4 quarters |
| Herbalife Nutrition Ltd | < 0.1% | 204,848 | 9.1M USD | −30.3% reduced | Q4 2020 2 quarters |
| MCK McKesson Corporation | < 0.1% | 45,629 | 8.9M USD | −81.5% reduced | Q3 2020 3 quarters |
| UHS Universal Health Services | < 0.1% | 66,639 | 8.9M USD | −73.6% reduced | Q3 2020 3 quarters |
| Cytokinetics Inc | < 0.1% | 374,600 | 8.7M USD | −67.9% reduced | Q2 2019 8 quarters |
| Graftech Intl Ltd | < 0.1% | 688,300 | 8.4M USD | −2.3% reduced | Q1 2020 5 quarters |
| Magna Intl Inc | < 0.1% | 95,583 | 8.4M USD | −53.6% reduced | Q4 2020 2 quarters |
| RSG Republic Services | < 0.1% | 83,096 | 8.3M USD | −63.5% reduced | Q2 2020 4 quarters |
| Abercrombie & Fitch Co | < 0.1% | 235,606 | 8.1M USD | −29.7% reduced | Q2 2020 4 quarters |
| Dolby Laboratories Inc | < 0.1% | 80,700 | 8.0M USD | −59.8% reduced | Q4 2020 2 quarters |
| ADBE Adobe Inc. | < 0.1% | 16,641 | 7.9M USD | −27.1% reduced | Q4 2020 2 quarters |
| Texas Roadhouse Inc | < 0.1% | 80,481 | 7.7M USD | −87.3% reduced | Q1 2020 5 quarters |
| Atara Biotherapeutics Inc | < 0.1% | 537,100 | 7.7M USD | −52.3% reduced | Q4 2020 2 quarters |
| KDP Keurig Dr Pepper | < 0.1% | 223,253 | 7.7M USD | −61.5% reduced | Q1 2020 5 quarters |
| Championx Corporation | < 0.1% | 351,964 | 7.6M USD | −52.1% reduced | Q2 2020 4 quarters |
| HIG Hartford (The) | < 0.1% | 113,500 | 7.6M USD | −59.2% reduced | Q4 2020 2 quarters |
| CF CF Industries | < 0.1% | 164,800 | 7.5M USD | −40.2% reduced | Q4 2020 2 quarters |
| TEAM Atlassian | < 0.1% | 34,560 | 7.3M USD | −76.4% reduced | Q4 2020 2 quarters |
| Oshkosh Corp | < 0.1% | 58,800 | 7.0M USD | −41.5% reduced | Q4 2020 2 quarters |
| Oge Energy Corp | < 0.1% | 214,607 | 6.9M USD | −37.7% reduced | Q3 2020 3 quarters |
| Moneygram Intl Inc | < 0.1% | 1,045,532 | 6.9M USD | −54.1% reduced | Q4 2020 2 quarters |
| DOV Dover Corporation | < 0.1% | 50,000 | 6.9M USD | −71.4% reduced | Q3 2018 11 quarters |
| Fulcrum Therapeutics Inc | < 0.1% | 575,246 | 6.8M USD | −57.0% reduced | Q2 2020 4 quarters |
| RL Ralph Lauren Corporation | < 0.1% | 54,232 | 6.7M USD | −84.6% reduced | Q4 2020 2 quarters |
| Brinks Co | < 0.1% | 79,000 | 6.3M USD | −46.9% reduced | Q4 2020 2 quarters |
| Relmada Therapeutics Inc | < 0.1% | 172,500 | 6.1M USD | −39.5% reduced | Q2 2020 4 quarters |
| ON ON Semiconductor | < 0.1% | 145,000 | 6.0M USD | −86.5% reduced | Q1 2019 9 quarters |
| VTRS Viatris | < 0.1% | 422,200 | 5.9M USD | −63.7% reduced | Q4 2020 2 quarters |
| Hexcel Corp New | < 0.1% | 99,045 | 5.5M USD | −75.9% reduced | Q4 2020 2 quarters |
| CARR Carrier Global | < 0.1% | 131,157 | 5.5M USD | −30.5% reduced | Q1 2020 5 quarters |
| Agios Pharmaceuticals Inc | < 0.1% | 101,100 | 5.2M USD | −43.7% reduced | Q1 2020 5 quarters |
| Diamedica Therapeutics Inc | < 0.1% | 552,250 | 5.1M USD | −31.0% reduced | Q3 2020 3 quarters |
| Madison Square Grdn Sprt Cor | < 0.1% | 28,098 | 5.0M USD | −69.3% reduced | Q3 2020 3 quarters |
| Zymeworks Inc | < 0.1% | 158,600 | 5.0M USD | −80.5% reduced | Q3 2020 3 quarters |
| PH Parker Hannifin | < 0.1% | 15,865 | 5.0M USD | −71.2% reduced | Q1 2020 5 quarters |
| Sanderson Farms Inc | < 0.1% | 31,700 | 4.9M USD | −59.2% reduced | Q4 2020 2 quarters |
| Avnet Inc | < 0.1% | 115,538 | 4.8M USD | −81.4% reduced | Q4 2020 2 quarters |
| Discover Finl Svcs | < 0.1% | 50,000 | 4.8M USD | −80.8% reduced | Q3 2020 3 quarters |
| Vale S A | < 0.1% | 272,079 | 4.7M USD | −72.1% reduced | Q2 2019 8 quarters |
| Domtar Corp | < 0.1% | 125,100 | 4.6M USD | −14.9% reduced | Q4 2019 6 quarters |
| FITB Fifth Third Bancorp | < 0.1% | 121,100 | 4.5M USD | −4.9% reduced | Q3 2020 3 quarters |
| Ascendis Pharma A/S | < 0.1% | 35,000 | 4.5M USD | −16.1% reduced | Q4 2020 2 quarters |
| Praxis Precision Medicines I | < 0.1% | 136,995 | 4.5M USD | −45.2% reduced | Q4 2020 2 quarters |
| 10X Genomics Inc | < 0.1% | 23,860 | 4.3M USD | −88.6% reduced | Q1 2020 5 quarters |
| Tim S A | < 0.1% | 378,256 | 4.3M USD | −47.7% reduced | Q4 2020 2 quarters |
| Allena Pharmaceuticals | < 0.1% | 3,000,000 | 4.2M USD | −25.0% reduced | Q4 2020 2 quarters |
| Aurinia Pharmaceuticals Inc | < 0.1% | 314,565 | 4.1M USD | −85.3% reduced | Q1 2019 9 quarters |
| Popular Inc | < 0.1% | 56,900 | 4.0M USD | −88.2% reduced | Q4 2016 18 quarters |
| KO Coca-Cola Company (The) | < 0.1% | 75,351 | 4.0M USD | −89.6% reduced | Q1 2020 5 quarters |
| Mei Pharma Inc | < 0.1% | 1,150,200 | 3.9M USD | −17.8% reduced | Q2 2020 4 quarters |
| Dmy Technology Group Inc II | < 0.1% | 261,774 | 3.9M USD | −28.7% reduced | Q4 2020 2 quarters |
| Cdk Global Inc | < 0.1% | 69,564 | 3.8M USD | −57.3% reduced | Q2 2020 4 quarters |
| Boot Barn HLDGS Inc | < 0.1% | 57,978 | 3.6M USD | −64.5% reduced | Q4 2020 2 quarters |
| Syneos Health Inc | < 0.1% | 46,001 | 3.5M USD | −72.9% reduced | Q4 2020 2 quarters |
| Growgeneration Corp | < 0.1% | 66,600 | 3.3M USD | −84.1% reduced | Q4 2020 2 quarters |
| Select Sector SPDR TR | < 0.1% | 50,987 | 3.3M USD | −58.2% reduced | Q1 2020 5 quarters |
| Repare Therapeutics Inc | < 0.1% | 100,000 | 3.1M USD | −67.0% reduced | Q4 2020 2 quarters |
| Immunovant Inc | < 0.1% | 187,900 | 3.0M USD | −27.3% reduced | Q1 2020 5 quarters |
| Ptc Therapeutics Inc | < 0.1% | 63,509 | 3.0M USD | −93.3% reduced | Q3 2018 11 quarters |
| Dave & Busters Entmt Inc | < 0.1% | 62,332 | 3.0M USD | −92.4% reduced | Q2 2020 4 quarters |
| Constellation Pharmceticls I | < 0.1% | 114,932 | 2.7M USD | −42.4% reduced | Q4 2019 6 quarters |
| Jaws Acquisition Corp | < 0.1% | 200,000 | 2.7M USD | −51.7% reduced | Q4 2020 2 quarters |
| DUK Duke Energy | < 0.1% | 26,600 | 2.6M USD | −95.1% reduced | Q4 2019 6 quarters |
| SPDR Gold TR | < 0.1% | 16,000 | 2.6M USD | −62.4% reduced | Q1 2020 5 quarters |
| Inogen Inc | < 0.1% | 48,600 | 2.6M USD | −69.5% reduced | Q4 2020 2 quarters |
| Axsome Therapeutics Inc | < 0.1% | 42,300 | 2.4M USD | −45.4% reduced | Q1 2020 5 quarters |
| Roku Inc | < 0.1% | 7,219 | 2.4M USD | −93.7% reduced | Q2 2020 4 quarters |
| Joyy Inc | < 0.1% | 24,900 | 2.3M USD | −61.1% reduced | Q2 2020 4 quarters |
| Triterras Inc | < 0.1% | 1,403,501 | 2.3M USD | −12.5% reduced | Q4 2020 2 quarters |
| Calix Inc | < 0.1% | 66,244 | 2.3M USD | −62.3% reduced | Q3 2020 3 quarters |
| Mks Instrs Inc | < 0.1% | 11,024 | 2.0M USD | −80.3% reduced | Q1 2019 9 quarters |
| Cyberark Software Ltd | < 0.1% | 15,700 | 2.0M USD | −95.0% reduced | Q2 2020 4 quarters |
| Enerplus Corp | < 0.1% | 400,000 | 2.0M USD | −65.2% reduced | Q4 2018 10 quarters |
| Fortis Inc | < 0.1% | 46,000 | 2.0M USD | −80.0% reduced | Q1 2020 5 quarters |
| Globus Med Inc | < 0.1% | 31,300 | 1.9M USD | −87.4% reduced | Q2 2020 4 quarters |
| WRB W. R. Berkley Corporation | < 0.1% | 25,000 | 1.9M USD | −95.5% reduced | Q2 2020 4 quarters |
| Arcelormittal SA Luxembourg | < 0.1% | 64,000 | 1.9M USD | −92.1% reduced | Q3 2020 3 quarters |
| FIS Fidelity National Information Services | < 0.1% | 13,097 | 1.8M USD | −97.8% reduced | Q1 2019 9 quarters |
| Calithera Biosciences Inc | < 0.1% | 760,500 | 1.8M USD | −55.3% reduced | Q2 2019 8 quarters |
| G III Apparel Group Ltd | < 0.1% | 58,600 | 1.8M USD | −32.3% reduced | Q3 2020 3 quarters |
| New Oriental Ed & Technology | < 0.1% | 121,800 | 1.7M USD | −20.4% reducedafter 10:1 stock split | Q3 2020 3 quarters |
| Miniso Group Hldg Ltd | < 0.1% | 70,200 | 1.7M USD | −82.4% reduced | Q4 2020 2 quarters |
| Tilray Inc | < 0.1% | 72,700 | 1.7M USD | −89.5% reduced | Q4 2020 2 quarters |
| Taro Pharmaceutical Inds Ltd | < 0.1% | 21,900 | 1.6M USD | −47.9% reduced | Q4 2020 2 quarters |
| Liberty Broadband Corp | < 0.1% | 9,500 | 1.4M USD | −89.7% reduced | Q2 2020 4 quarters |
| Energizer HLDGS Inc New | < 0.1% | 29,800 | 1.4M USD | −84.6% reduced | Q2 2020 4 quarters |
| Via Optronics AG | < 0.1% | 107,700 | 1.4M USD | −2.1% reduced | Q3 2020 3 quarters |
| Petroleo Brasileiro SA Petro | < 0.1% | 159,900 | 1.4M USD | −88.0% reduced | Q2 2020 4 quarters |
| Switch Inc | < 0.1% | 82,900 | 1.3M USD | −85.0% reduced | Q2 2020 4 quarters |
| Allete Inc | < 0.1% | 19,400 | 1.3M USD | −66.1% reduced | Q2 2020 4 quarters |
| Tactile Sys Technology Inc | < 0.1% | 22,900 | 1.2M USD | −81.8% reduced | Q3 2020 3 quarters |
| Webster Finl Corp Conn | < 0.1% | 21,500 | 1.2M USD | −88.7% reduced | Q4 2020 2 quarters |
| Nmi HLDGS Inc | < 0.1% | 50,000 | 1.2M USD | −91.1% reduced | Q1 2020 5 quarters |
| LII Lennox International | < 0.1% | 3,666 | 1.1M USD | −78.1% reduced | Q2 2019 8 quarters |
| Heron Therapeutics Inc | < 0.1% | 65,000 | 1.1M USD | −41.1% reduced | Q3 2020 3 quarters |
| Gopro Inc | < 0.1% | 88,800 | 1.0M USD | −18.3% reduced | Q3 2020 3 quarters |
| Surface Oncology Inc | < 0.1% | 121,250 | 946.0K USD | −70.8% reduced | Q3 2020 3 quarters |
| CELH Celsius Holdings | < 0.1% | 19,500 | 937.0K USD | −80.0% reduced | Q3 2020 3 quarters |
| Otonomy Inc | < 0.1% | 355,000 | 905.0K USD | −84.9% reduced | Q1 2020 5 quarters |
| Ncino Inc | < 0.1% | 12,200 | 814.0K USD | −91.1% reduced | Q4 2020 2 quarters |
| Quantumscape Corp | < 0.1% | 17,715 | 793.0K USD | −66.3% reduced | Q4 2020 2 quarters |
| 908 Devices Inc | < 0.1% | 15,200 | 737.0K USD | −51.7% reduced | Q4 2020 2 quarters |
| Overstock Com Inc Del | < 0.1% | 9,500 | 629.0K USD | −93.2% reduced | Q4 2020 2 quarters |
| Burlington Stores Inc | < 0.1% | 2,079 | 621.0K USD | −98.4% reduced | Q4 2020 2 quarters |
| Simply Good Foods Co | < 0.1% | 20,200 | 614.0K USD | −96.5% reduced | Q4 2018 10 quarters |
| SHIFT4 Pmts Inc | < 0.1% | 6,800 | 558.0K USD | −98.1% reduced | Q3 2020 3 quarters |
| Docusign Inc | < 0.1% | 2,651 | 537.0K USD | −97.1% reduced | Q1 2020 5 quarters |
| Dragoneer Growth Oppty Corp | < 0.1% | 50,000 | 514.0K USD | −41.2% reduced | Q4 2020 2 quarters |
| Qell Acquisition Corp | < 0.1% | 50,000 | 509.0K USD | −75.0% reduced | Q4 2020 2 quarters |
| Dragoneer Growth Opportun Co | < 0.1% | 50,000 | 508.0K USD | −92.0% reduced | Q4 2020 2 quarters |
| CSGP CoStar Group | < 0.1% | 600 | 493.0K USD | −98.2% reduced | Q1 2019 9 quarters |
| Vonage HLDGS Corp | < 0.1% | 36,200 | 428.0K USD | −98.6% reduced | Q4 2018 10 quarters |
| Lands End Inc New | < 0.1% | 13,700 | 340.0K USD | −46.7% reduced | Q4 2020 2 quarters |
| Triterras Inc | < 0.1% | 40,711 | 295.0K USD | −97.1% reduced | Q4 2020 2 quarters |
| Shoe Carnival Inc | < 0.1% | 4,000 | 248.0K USD | −42.9% reduced | Q3 2020 3 quarters |
| Silver Spike Acquisition Cor | < 0.1% | 13,207 | 242.0K USD | −95.2% reduced | Q4 2020 2 quarters |
| Ishares Inc | < 0.1% | 5,000 | 219.0K USD | −83.3% reduced | Q4 2020 2 quarters |
| Verint Sys Inc | < 0.1% | 4,500 | 205.0K USD | −97.1% reduced | Q4 2020 2 quarters |
| Virtus Invt Partners Inc | < 0.1% | 500 | 118.0K USD | −80.8% reduced | Q1 2020 5 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Plus 54 option positions, value of the underlying shares as reported 1.8B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 919.5M USD
- Invesco QQQ TR Put 255.3M USD
- SPDR Ser TR Put 88.2M USD
- Las Vegas Sands Call 85.4M USD
- Uber Call 49.1M USD
- Merck & Co. Call 38.5M USD
- Ishares TR Call 29.2M USD
- Advisorshares TR Call 25.4M USD
- Visa Inc. Call 21.2M USD
- Tesla, Inc. Put 20.0M USD
Breakdown by sector
- Technology 11.1%
- Health Care 6.7%
- Industrials 6.7%
- Consumer Discretionary 6.0%
- Financials 5.6%
- Communication Services 3.9%
- Consumer Staples 2.8%
- Utilities 2.4%
- Energy 1.4%
- Materials 0.6%
- Real Estate 0.1%
- not in our coverage 52.6%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors